Activated autologous CD8+ T cells and decreased the expression of p-AKT/p-ERK/p-MEK in mouse tumor models [105];no association between post-diagnostic β-blocker and specific mortality [106]. This evidence concerns the gene MAP2K7 and neoplasm.